Archive for the ‘Bio-terrorism / Terrorism’ Category

SRI International Awarded Defense Threat Reduction Agency Contract To R&D Broad-Spectrum Antibiotics

Tuesday, September 23rd, 2008
SRI International, an independent nonprofit research and development organization, announced it has been awarded a contract to develop broad-spectrum antibiotics from the Defense Threat Reduction Agency (DTRA), an agency within the United States Department of Defense (DoD). The new three-year, $8.

Emergent BioSolutions Receives $24 Million Development Contract From The DHH To Fund Continued Development Of Anthrax Monoclonal Antibody

Friday, September 5th, 2008
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has received a contract from the Department of Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent's anthrax monoclonal antibody AVP-21D9.

Bombmakers Could Be Identified Using Fingerprint Analysis Technique

Thursday, August 28th, 2008
University of Leicester experts have held discussions with military personnel in Afghanistan following the discovery of new technology to identify fingerprints on metal.

Fairway Medical Technologies To Develop Biosensor For Blood Pathogens And Warfare Threats

Monday, August 25th, 2008
Fairway Medical Technologies, Inc. has received a $900,000, 3-year contract from the Department of the Navy to apply its optoacoustic technology to the real-time detection of blood borne pathogens and biological warfare agents under battlefield conditions. This grant is part of a larger, $3 million project led by Prof.

Science Of Anthrax Investigation Unveilled By FBI

Sunday, August 24th, 2008
They have worked for almost seven years in secret. Most people did not know that the work in Ray Goehner's materials characterization department at Sandia National Laboratories was contributing important information to the FBI's investigation of letters containing bacillus anthracis, the spores that cause the disease anthrax.

Rapid Test For Pathogens Developed By K-State Researchers Could Be Used To Detect Diseases Used By Bioterrorists

Friday, August 22nd, 2008
Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.

Ricin’s Deadly Action Revealed By Glowing Probes

Friday, August 8th, 2008
A new chemical probe can rapidly detect ricin, a deadly poison with no known antidote that is feared to be a potential weapon for terrorists and cannot quickly be identified with currently available tests.

Anthrax Scientist Was Planning To Kill Co-Workers Therapist Told Court

Monday, August 4th, 2008
Dr Bruce E Ivins, the 62-yar-old US biodefense scientist who was reportedly going to be charged with killing five people by mailing them letters containing finelly milled anthrax spores in 2001, was planning to kill his co-workers, a therapist told a Maryland court on 24th July, a week before Ivins committed suicide.

Development And Procurement Of A Recombinant Protective Antigen Anthrax Vaccine

Saturday, August 2nd, 2008
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a proposal in response to a request for proposal (RFP) issued by the U.S. Department of Health and Human Services (HHS) for a recombinant protective antigen anthrax vaccine (rPA). Emergent's rPA vaccine candidate is a reformulated and more stable form of the rPA 102 vaccine originally developed at the U.S.

UCF Professor Develops Vaccine To Protect Against Black Plague Bioterror Attack

Thursday, July 31st, 2008
A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a vaccine that early research shows is highly effective against the plague.